|
| | 
|
 | |
        
|  |
|  |
|
| PS: The quotes after 2018-12-04 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Pfizer Static Chart |
 Pfizer - [Ticker: PFE] |     | | Last Trade | 45.14 | Last Trade Time | 2018-12-04 - 00:00:00 | | Variation | --0.85 (+0.98%) | Open | 46.23 | | High | 46.47 | Low | 45.11 | | Volume | 26,062,310 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 35.33 x 5,700 - 35.34 x 8,100 | | Former Close | 45.99 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
|
News about Pfizer [PFE]: (ordered by relevance)
| - BioNTech/Pfizer say Omicron-targeting boosters elicit strong immune response Financial Times
- Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron Pfizer
- Pfizer says tweaked COVID-19 shots boost omicron protection The Independent
- Pfizer and BioNTech say updated Covid-19 boosters show increased immune response against Omicron variant CNN
- Pfizer says its Omicron-containing boosters outperform current vaccine STAT
Pfizer's Russian profit donation plan running smoothly, CEO says FiercePharma
How To Buy Pfizer (PFE) Stock ? Forbes Advisor Canada Forbes
Valneva and Pfizer Announce Closing of Equity Investment Pfizer
Pfizer CEO: What's next for vaccines, tech and the pandemic World Economic Forum
Hedeker Wealth LLC Sells 39847 Shares of Pfizer Inc. (NYSE:PFE) Defense World
Pfizer is first big pharma to tap Truveta's real-world data platform - pharmaphorum
CVS Health returns BMS, Pfizer's Eliquis to formulary FiercePharma
Freedom of Information request on the ingredients in the Pfizer COVID-19 vaccination (FOI 22/403) GOV.UK
BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's FiercePharma
CHoMP: Westphal's Dem gobbles up $70M in Pfizer-backed round to fund macrophage cancer R&D FierceBiotech
Pfizer to exit GSK consumer health joint venture after London listing Financial Times
Young Men's Myocarditis Risk 5 Times Higher With Moderna vs Pfizer Vax Medpage Today
Pfizer and BioNTech Provide Update on Rolling Submission to European Medicines Agency for a Potential Variant-Adapted Vaccine Pfizer
Pfizer Completes Acquisition of ReViral Pfizer
Pfizer sets sights on elimination of blinding disease trachoma by 2030 - Health - Life & Style Ahram Online
Pfizer Invests $120 Million in Paxlovid Production Investopedia
3 reasons why Pfizer (NYSE:PFE) might be a great buy Motley Fool UK
Pfizer Reports Additional Data on PAXLOVID? Supporting Upcoming New Drug Application Submission to US FDA Pfizer
Enanta lawsuit claims Pfizer's Paxlovid infringes its patent - pharmaphorum
Why Pfizer, BioNTech, and Moderna Stocks Are Sinking Today The Motley Fool
Pfizer-BioNTech shot for children under 5 safe and effective, FDA staff says The Washington Post
Pfizer Covid Vaccine Protects Against Omicron Sublineages BA.4 and BA.5: Study Bloomberg
Pfizer shoots back at Alnylam's claims in high-stakes COVID-19 vaccine patent case FiercePharma
Why Moderna and Pfizer Lagged the Market Today The Motley Fool
Health Product Market Outlook 2022 And Growth By Top KeyPlayers ? Pfizer, Nestle, Arbonne, GSK ? Designer Women Designer Women
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Nasdaq
Pfizer seeks authorization of coronavirus shot for children under 5 The Washington Post
Pfizer Stock: The Pain Might Not Be Over (NYSE:PFE) Seeking Alpha
Freedom of Information request on temporary authorisations of the Pfizer/BioNTech, Oxford/AstraZeneca and Moderna vaccines which were done through an expedited rolling review (FOI 21-1228) GOV.UK
Pfizer Presents First Data from Planned Interim Analysis of Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab Under Investigation for Relapsed/Refractory Multiple Myeloma Pfizer
Pfizer and BioNTech Announced Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Respons Benzinga
Pfizer's vaccine raked in $37 billion in 2021 - nearly doubling the revenue of every other drug Daily Mail
Pfizer Inc. (NYSE:PFE) Receives Average Rating of "Moderate Buy" from Analysts MarketBeat
Pfizer Inc. (NYSE:PFE) Announces Quarterly Dividend of $0.40 MarketBeat
GSK Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck Investor's Business Daily
Pfizer Inc. (PFE) CEO Albert Bourla Presents at the Bernstein 38th Annual Strategic Decisions Conference (Transcript) Seeking Alpha
Diflorasone Market Research With Sanofi, Pfizer, Novartis, Sun Pharma, Dérmico Farm | To reach good valuation as discussed in a new report ? Indian Defence News Indian Defence News
Pfizer Inc. (NYSE:PFE) Short Interest Up 33.9% in May MarketBeat
Axis Bank, JK Cement, PFizer among 171 BSE stocks to hit new 52-week lows; Kohinoor Foods at new high The Financial Express
Pfizer to offer all its drugs not-for-profit to 45 lower-income countries The Guardian
Investing in Pfizer Stock (PFE) Investopedia
Veterinary Diagnostic Market Outlook 2022 And Growth By Top KeyPlayers ? Pfizer, Thermo Fisher Scientific, Henry Schein, Virbac ? Designer Women Designer Women
Pfizer to buy biotech group Biohaven for $11.6bn Financial Times
Pfizer accused of pandemic profiteering as profits double The Guardian
Will Pfizer Stock Continue To Rise? Forbes
Pfizer Completes Acquisition of Arena Pharmaceuticals Pfizer
What's Next For Pfizer Stock After A 10% Fall In A Month? Forbes
Pfizer Updates Company Position in Russia Pfizer
Pfizer to Acquire Arena Pharmaceuticals Pfizer
The inside story of the Pfizer vaccine: 'a once-in-an-epoch windfall' Financial Times
Why Pfizer Stock Climbed Today The Motley Fool
Moderna and Pfizer urged to share vaccine technology with developing world Financial Times
Agreement with BioNTech-Pfizer to adapt delivery schedules European Commission
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose Pfizer
Why Pfizer Stock Rose Today While the Market Tanked The Motley Fool
Is it Still Worthy to Invest in Pfizer (PFE)? Yahoo Finance
Why Pfizer Has a Wide Moat Morningstar
Pfizer warns of 'constant waves' of Covid as complacency grows Financial Times
Pfizer Announces 2022 Shareholder Meeting Preliminary Results Pfizer
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission Pfizer
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases Pfizer
Pfizer Is Under Pressure Today, Here Is Why Yahoo Finance
Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling? CNN
Pfizer and BioNTech Receive Positive CHMP Opinion for COVID-19 Vaccine Booster in Adolescents 12 through 17 Years of Age in the European Union Pfizer
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age Pfizer
Can the momentum continue for Pfizer (NYQ:PFE)? Yahoo Finance UK
The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know World Health Organization
Pfizer and BioNTech Submit for US Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults Pfizer
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference Pfizer
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age Pfizer
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From US FDA Pfizer
Pfizer Announces New Chief Development Officer Pfizer
Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged Al Jazeera English
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates Pfizer
Manufacturing Sites: Made in the USA Pfizer
Why Pfizer Stock Rose 10.3% in March The Motley Fool
Pfizer and BioNTech Granted US Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age Pfizer
Pfizer strikes deal to allow generic versions of its Covid pill for world?s poor The Guardian
Pfizer says three vaccine doses offer protection against Omicron Financial Times
Pfizer Invests $68.5 Million in New State-of-the-Art Facility in Durham, North Carolina to Further Advance Gene Therapy Capabilities Pfizer
Pfizer & Moderna Investors Run for the Exits The Desert Review
Pfizer Declares Second-Quarter 2022 Dividend Pfizer
Pfizer and BioNTech Submit Application for US Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age Pfizer
This Insider Has Just Sold Shares In Pfizer Inc. (NYSE:PFE) Simply Wall St
WHO urges Pfizer to make Covid antiviral drug pricing more transparent Financial Times
Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential Pfizer
Pfizer raises 2021 sales forecast for Covid vaccine to $36bn Financial Times
Pfizer and BioNTech Provide Update on Ongoing Studies of COVID-19 Vaccine Pfizer
Pfizer and BioNTech team up to develop mRNA-based shingles vaccine Financial Times
Pfizer Stock: How Pfizer's Nearly $7 Billion Takeover Of Arena Just Paid Off Investor's Business Daily
Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding The Motley Fool
Pfizer, BioNTech and Moderna making $1000 profit every second while world's poorest countries remain largely unvaccinated - World ReliefWeb
Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Pfizer
Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month Forbes
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID? for Post-Exposure Prophylactic Use Pfizer
Pfizer Stock: Vaccine Has Provided A Long-Term Boost (NYSE:PFE) Seeking Alpha
Pfizer (PFE) Paxlovid Withheld From Researchers Studying Drug Combinations Bloomberg
Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28 Pfizer
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death Pfizer
| For more news about Pfizer click here:
Pfizer News |
|
Website Width:
Background image: |
|  | |
|
|
